↓ Skip to main content

Long-term safety and impact of immune recovery in heavily treatment-experienced adults receiving fostemsavir for up to 5 years in the phase 3 BRIGHTE study

Overview of attention for article published in Frontiers in immunology, May 2024
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (52nd percentile)
  • Good Attention Score compared to outputs of the same age and source (79th percentile)

Mentioned by

twitter
4 X users

Readers on

mendeley
3 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Long-term safety and impact of immune recovery in heavily treatment-experienced adults receiving fostemsavir for up to 5 years in the phase 3 BRIGHTE study
Published in
Frontiers in immunology, May 2024
DOI 10.3389/fimmu.2024.1394644
Pubmed ID
Authors

Josep M. Llibre, Judith A. Aberg, Sharon Walmsley, Juan Velez, Carlos Zala, Brenda Crabtree Ramírez, Bronagh Shepherd, Rimi Shah, Andrew Clark, Allan R. Tenorio, Amy Pierce, Fangfang Du, Bo Li, Marcia Wang, Shiven Chabria, Michael Warwick-Sanders

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 3 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 3 100%

Demographic breakdown

Readers by professional status Count As %
Other 2 67%
Student > Master 1 33%
Readers by discipline Count As %
Medicine and Dentistry 2 67%
Environmental Science 1 33%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 June 2024.
All research outputs
#16,753,508
of 26,393,142 outputs
Outputs from Frontiers in immunology
#17,504
of 33,107 outputs
Outputs of similar age
#140,282
of 317,024 outputs
Outputs of similar age from Frontiers in immunology
#155
of 864 outputs
Altmetric has tracked 26,393,142 research outputs across all sources so far. This one is in the 34th percentile – i.e., 34% of other outputs scored the same or lower than it.
So far Altmetric has tracked 33,107 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.6. This one is in the 42nd percentile – i.e., 42% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 317,024 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 52% of its contemporaries.
We're also able to compare this research output to 864 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 79% of its contemporaries.